This title appears in the Scientific Report :
2021
Please use the identifier:
http://hdl.handle.net/2128/28119 in citations.
Mo-99 production at HBS
Mo-99 production at HBS
Mo-99 is the precursor of Tc-99m which is the most widely used medical isotope fordiagnostic with 30 to 40 million examinations worldwide per year (3 millionexaminations alone in Germany). Mo-99 is mainly produced by fission of U-235 withthermal neutrons in high flux reactors. The planned shutdown o...
Saved in:
Personal Name(s): | Mauerhofer, Eric (Corresponding author) |
---|---|
Contributing Institute: |
Streumethoden; JCNS-2 High Brilliance Source; JCNS-HBS JARA-FIT; JARA-FIT Streumethoden; PGI-4 |
Imprint: |
2021
|
Conference: | Digital Institute Seminar JCNS-2 (online event), |
Document Type: |
Talk (non-conference) |
Research Program: |
Jülich Centre for Neutron Research (JCNS) (FZJ) Materials – Quantum, Complex and Functional Materials |
Link: |
OpenAccess |
Publikationsportal JuSER |
Mo-99 is the precursor of Tc-99m which is the most widely used medical isotope fordiagnostic with 30 to 40 million examinations worldwide per year (3 millionexaminations alone in Germany). Mo-99 is mainly produced by fission of U-235 withthermal neutrons in high flux reactors. The planned shutdown of 3 reactors in Europewill cause in the near future a reduction of about 60% of the Mo-99 production inEurope and thereby generate a supply shortage. Since no new reactors will be builtalternative methods are urgently required. A short overview of accelerator-basedtechniques is given. Preliminary results on the Mo-99 production at HBS arepresented and discussed. |